2617 — TransThera Sciences (Nanjing) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$11.01bn
- HK$11.02bn
Annual cashflow statement for TransThera Sciences (Nanjing), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -343 | -275 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | -19.1 | 3.34 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 35.7 | -6.35 |
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -319 | -271 |
| Capital Expenditures | -11.8 | -0.773 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | -175 | 349 |
| Sale of Fixed Assets | ||
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Cash from Investing Activities | -187 | 348 |
| Financing Cash Flow Items | -0.734 | -1.64 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 15.8 | -4.87 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -487 | 72.9 |